Sökning: WFRF:(Ronn SG) > Suppressor of cytok...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02635naa a2200313 4500 | |
001 | oai:prod.swepub.kib.ki.se:1940219 | |
003 | SwePub | |
008 | 240913s2006 | |||||||||||000 ||eng| | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:19402192 URI |
024 | 7 | a https://doi.org/10.1210/me.2005-03012 DOI |
040 | a (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Frobose, H4 aut |
245 | 1 0 | a Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex |
264 | 1 | b The Endocrine Society,c 2006 |
520 | a IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor κ B (NFκB) and MAPKs. Although a great deal is known about the mechanism of activation of NFκB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFκB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFκB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFβ-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1. | |
700 | 1 | a Ronn, SG4 aut |
700 | 1 | a Heding, PE4 aut |
700 | 1 | a Mendoza, H4 aut |
700 | 1 | a Cohen, P4 aut |
700 | 1 | a Mandrup-Poulsen, T4 aut |
700 | 1 | a Billestrup, N4 aut |
773 | 0 | t Molecular endocrinology (Baltimore, Md.)d : The Endocrine Societyg 20:7, s. 1587-1596q 20:7<1587-1596x 0888-8809x 1944-9917 |
856 | 4 | u https://academic.oup.com/mend/article-pdf/20/7/1587/10719437/mend1587.pdf |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:1940219 |
856 | 4 8 | u https://doi.org/10.1210/me.2005-0301 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy